We did not detect a significant change of 4EBP1 phosphorylation in AML cells treated with rapamycin, which is consistent with previous published results suggesting that the effect of rapamycin on 4EBP1 is cell type dependent57,58 (Fig. 5d). Here, EIF4EBP1 is linked to acute myeloid leukemia.